United-Guardian, Inc. (NASDAQ:UG) Stock Short Interest Report for October

United-Guardian, Inc. (NASDAQ:UG) was the recipient of a significant decline in short interest during the month of October. As of October 15th, there was short interest totaling 7,555 shares, a decline of 39.1% from the September 30th total of 12,413 shares. Approximately 0.2% of the shares of the stock are sold short. Based on an average trading volume of 13,933 shares, the days-to-cover ratio is currently 0.5 days.

Analyst Upgrades and Downgrades

Separately, Weiss Ratings restated a “hold (c)” rating on shares of United-Guardian in a report on Monday, October 19th. One equities research analyst has rated the stock with a Hold rating. According to data from MarketBeat.com, the company has an average rating of “Hold”.

Institutional Trading of United-Guardian

Hedge funds have recently made changes to their positions in the stock. United Capital Financial Advisors LLC acquired a new stake in shares of United-Guardian in the 2nd quarter worth approximately $143,000. BlackRock Inc. acquired a new stake in shares of United-Guardian during the second quarter worth approximately $105,000. Finally, Gamco Investors INC. ET AL grew its stake in United-Guardian by 1.2% in the first quarter. Gamco Investors INC. ET AL now owns 164,388 shares of the company’s stock valued at $1,101,000 after purchasing an additional 1,888 shares in the last quarter. Institutional investors own 23.16% of the company’s stock.

United-Guardian Stock Up 6.2%

NASDAQ UG opened at $7.07 on Friday. The firm has a market cap of $32.45 million, a P/E ratio of 13.09 and a beta of 0.95. The business’s 50-day moving average price is $7.05 and its 200 day moving average price is $6.95. United-Guardian has a 52-week low of $5.58 and a 52-week high of $8.45.

United-Guardian (NASDAQ:UG) last issued its quarterly earnings data on Friday, August 7th. The company reported $0.16 EPS for the quarter. The firm had revenue of $3.11 million for the quarter. United-Guardian had a net margin of 22.01% and a return on equity of 22.24%.

About United-Guardian

United-Guardian, Inc is a specialty chemicals company that develops, manufactures and markets products for the personal care, pharmaceutical and industrial markets. The company serves customers in the United States and international markets through direct sales, distributors and commercial partners.

Its personal care portfolio includes Lubrajel, a family of water-based moisturizing and lubricating gels used in skin-care, hair-care, cosmetic and personal lubricant formulations. United-Guardian also supplies specialty ingredients designed to improve the texture, moisture retention and performance of finished consumer products.

In the pharmaceutical sector, the company markets Renacidin, a solution used under medical supervision for certain urinary tract applications, including the prevention and dissolution of specific types of urinary encrustations and stones.